Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Kubient appoints Leon Zemel as Chief Product Officer » 07:20
04/14/21
04/14
07:20
04/14/21
07:20
KBNT

Kubient

$7.20 /

-0.06 (-0.83%)

Kubient has appointed…

Kubient has appointed Leon Zemel as the new Chief Product Officer. Zemel was most recently Senior VP of Programmatic and Platform Product at DoubleVerify. He has also driven product innovation for large scale ad:tech companies such as MediaMath in addition to leading all programmatic product at DoubleVerify. In addition to Zemel, Kubient also recently added two senior level team members: Larry Mlawksi joins the company as Director of Client Success, and Alexis Bryers, a former Sales Director at GeoEdge, joins the company as Vice President of KAI Partnerships.

ShowHide Related Items >><<
KBNT Kubient
$7.20 /

-0.06 (-0.83%)

KBNT Kubient
$7.20 /

-0.06 (-0.83%)

03/26/21 Maxim
Kubient price target raised to $13 from $10 at Maxim
10/27/20 Maxim
Kubient initiated with a Buy at Maxim
KBNT Kubient
$7.20 /

-0.06 (-0.83%)

  • 23
    Dec
KBNT Kubient
$7.20 /

-0.06 (-0.83%)

Options
new option listings and two option delistings on April 7th » 08:30
04/07/21
04/07
08:30
04/07/21
08:30
ACIC

Atlas Crest Investment Corp.

$10.18 /

+0.075 (+0.74%)

, ASTS

AST SpaceMobile

$11.61 /

-1.26 (-9.79%)

, CCV

Churchill Capital Corp V

$10.06 /

+0.12 (+1.21%)

, ENTX

Entera Bio

$3.47 /

-0.25 (-6.72%)

, GATO

Gatos Silver

$10.60 /

+0.32 (+3.11%)

, HCM

Hutchison China MediTech

$28.00 /

+0.15 (+0.54%)

, KBNT

Kubient

$7.50 /

+0.46 (+6.53%)

, NAPA

Duckhorn Portfolio

$17.56 /

+0.02 (+0.11%)

, OLO

Olo

$28.37 /

-0.66 (-2.27%)

, PCT

PureCycle Technologies

$25.71 /

-0.03 (-0.12%)

, PDSB

PDS Biotechnology

$5.00 /

+0.31 (+6.61%)

, SFTW

Osprey Technology Acquisition Corp.

$10.16 /

-0.01 (-0.10%)

, SHV

iShares Short Treasury Bond

$110.53 /

+0.01 (+0.01%)

, USFR

WisdomTree Floating Rate Treasury Fund

$25.11 /

+0.005 (+0.02%)

, VTIP

Vanguard Short-Term Inflation-Protected Securities ETF

$51.55 /

+0.02 (+0.04%)

, NPA

New Providence Acquisition Corp.

$0.00 /

+ (+0.00%)

, PS

Pluralsight

$22.45 /

+ (+0.00%)

New option listings for…

New option listings for April 7th include Atlas Crest Investment Corp (Class A Stock) (ACIC), ARK Space Exploration and Innovation (ARKX), AST SpaceMobile Inc (Class A Stock) (ASTS), Churchill Capital Corp V (Class A Stock) (CCV), Entera Bio Ltd (ENTX), Gatos Silver Inc (GATO), Hutchinson China MediTech (HCM), Kubient Inc (KBNT), Roundhill Mvp Etf (MVP), Duckhorn Portfolio Inc (NAPA), Olo Inc (Class A Stock) (OLO), PureCycle Technologies Inc (PCT), PDS Biotechnology Corp (PDSB), Osprey Technology Acquisition Corp (Class A Stock) (SFTW), iShares Treasury (SHV), SVF Investment Corporation (Units) (SVFAU), SPDR DoubleLine Total Return Tactical ETF (TOTL), WisdomTree Bloomberg Floating Rate Treasury Fund (USFR), Janus Henderson Short Duration Income ETF (VNLA), Vanguard Short Term Inflation Protected Securities Index Fund (VTIP), and Vanguard International High Dividend Yield ETN (VYMI). Option delistings effective April 7th include New Povidence Acquisition Corporation (Class A Stock) (NPA) and Pluralsight Inc (Class A Stock) (PS).

ShowHide Related Items >><<
SFTW Osprey Technology Acquisition Corp.
$10.16 /

-0.01 (-0.10%)

PS Pluralsight
$22.45 /

+ (+0.00%)

PDSB PDS Biotechnology
$5.00 /

+0.31 (+6.61%)

PCT PureCycle Technologies
$25.71 /

-0.03 (-0.12%)

OLO Olo
$28.37 /

-0.66 (-2.27%)

NPA New Providence Acquisition Corp.
$0.00 /

+ (+0.00%)

KBNT Kubient
$7.50 /

+0.46 (+6.53%)

HCM Hutchison China MediTech
$28.00 /

+0.15 (+0.54%)

GATO Gatos Silver
$10.60 /

+0.32 (+3.11%)

ENTX Entera Bio
$3.47 /

-0.25 (-6.72%)

ASTS AST SpaceMobile
$11.61 /

-1.26 (-9.79%)

ACIC Atlas Crest Investment Corp.
$10.18 /

+0.075 (+0.74%)

ACIC Atlas Crest Investment Corp.
$10.18 /

+0.075 (+0.74%)

ASTS AST SpaceMobile
$11.61 /

-1.26 (-9.79%)

CCV Churchill Capital Corp V
$10.06 /

+0.12 (+1.21%)

ENTX Entera Bio
$3.47 /

-0.25 (-6.72%)

03/22/21 Aegis
Entera Bio initiated with a Buy at Aegis
03/11/21 Maxim
Entera Bio price target raised to $10 from $5 at Maxim
GATO Gatos Silver
$10.60 /

+0.32 (+3.11%)

01/29/21 BMO Capital
Gatos Silver downgraded to Market Perform from Outperform at BMO Capital
11/24/20 BMO Capital
Gatos Silver initiated with an Outperform at BMO Capital
11/23/20 RBC Capital
Gatos Silver initiated with an Outperform at RBC Capital
HCM Hutchison China MediTech
$28.00 /

+0.15 (+0.54%)

10/02/20 Deutsche Bank
Hutchison China MediTech initiated with a Buy at Deutsche Bank
KBNT Kubient
$7.50 /

+0.46 (+6.53%)

03/26/21 Maxim
Kubient price target raised to $13 from $10 at Maxim
10/27/20 Maxim
Kubient initiated with a Buy at Maxim
NAPA Duckhorn Portfolio
$17.56 /

+0.02 (+0.11%)

OLO Olo
$28.37 /

-0.66 (-2.27%)

PCT PureCycle Technologies
$25.71 /

-0.03 (-0.12%)

03/18/21 Craig-Hallum
PureCycle Technologies initiated with a Buy at Craig-Hallum
PDSB PDS Biotechnology
$5.00 /

+0.31 (+6.61%)

03/19/21 H.C. Wainwright
PDS Biotechnology price target raised to $8 from $6 at H.C. Wainwright
11/10/20 H.C. Wainwright
PDS Biotechnology upgraded to Buy from Neutral at H.C. Wainwright
07/28/20 Alliance Global Partners
PDS Biotechnology price target raised to $6.50 from $4 at Alliance Global
05/27/20 Alliance Global Partners
PDS Biotechnology initiated with a Buy at Alliance Global Partners
SFTW Osprey Technology Acquisition Corp.
$10.16 /

-0.01 (-0.10%)

SHV iShares Short Treasury Bond
$110.53 /

+0.01 (+0.01%)

USFR WisdomTree Floating Rate Treasury Fund
$25.11 /

+0.005 (+0.02%)

VTIP Vanguard Short-Term Inflation-Protected Securities ETF
$51.55 /

+0.02 (+0.04%)

NPA New Providence Acquisition Corp.
$0.00 /

+ (+0.00%)

PS Pluralsight
$22.45 /

+ (+0.00%)

01/04/21 Truist
Pluralsight downgraded to Hold from Buy at Truist
01/04/21 Truist
Pluralsight downgraded to Hold from Buy at Truist
12/17/20 Barclays
Pluralsight downgraded to Equal Weight from Overweight at Barclays
12/15/20 Baird
Pluralsight downgraded to Neutral from Outperform at Baird
PS Pluralsight
$22.45 /

+ (+0.00%)

PDSB PDS Biotechnology
$5.00 /

+0.31 (+6.61%)

KBNT Kubient
$7.50 /

+0.46 (+6.53%)

HCM Hutchison China MediTech
$28.00 /

+0.15 (+0.54%)

ENTX Entera Bio
$3.47 /

-0.25 (-6.72%)

  • 18
    Mar
  • 17
    Mar
  • 23
    Dec
  • 28
    Oct
  • 11
    Aug
  • 10
    Jun
PS Pluralsight
$22.45 /

+ (+0.00%)

OLO Olo
$28.37 /

-0.66 (-2.27%)

NPA New Providence Acquisition Corp.
$0.00 /

+ (+0.00%)

SFTW Osprey Technology Acquisition Corp.
$10.16 /

-0.01 (-0.10%)

PS Pluralsight
$22.45 /

+ (+0.00%)

OLO Olo
$28.37 /

-0.66 (-2.27%)

NPA New Providence Acquisition Corp.
$0.00 /

+ (+0.00%)

NAPA Duckhorn Portfolio
$17.56 /

+0.02 (+0.11%)

KBNT Kubient
$7.50 /

+0.46 (+6.53%)

GATO Gatos Silver
$10.60 /

+0.32 (+3.11%)

CCV Churchill Capital Corp V
$10.06 /

+0.12 (+1.21%)

ASTS AST SpaceMobile
$11.61 /

-1.26 (-9.79%)

ACIC Atlas Crest Investment Corp.
$10.18 /

+0.075 (+0.74%)

PS Pluralsight
$22.45 /

+ (+0.00%)

NPA New Providence Acquisition Corp.
$0.00 /

+ (+0.00%)

SHV iShares Short Treasury Bond
$110.53 /

+0.01 (+0.01%)

Recommendations
Kubient price target raised to $13 from $10 at Maxim » 08:07
03/26/21
03/26
08:07
03/26/21
08:07
KBNT

Kubient

$6.93 /

+0.15 (+2.21%)

Maxim analyst Jack Vander…

Maxim analyst Jack Vander Aarde raised the firm's price target on Kubient to $13 from $10 and keeps a Buy rating on the shares. The company's Q4 revenue "significantly" beat his expectations, accelerating to 309% from Q3 as ad opportunities within its marketplace continued at a rapid pace, the analyst tells investors in a research note. Vander Aarde adds that Kubient's revenue growth will continue to accelerate as the company builds out its sales team to attract more demand-side customers.

ShowHide Related Items >><<
KBNT Kubient
$6.93 /

+0.15 (+2.21%)

KBNT Kubient
$6.93 /

+0.15 (+2.21%)

10/27/20 Maxim
Kubient initiated with a Buy at Maxim
KBNT Kubient
$6.93 /

+0.15 (+2.21%)

  • 23
    Dec
KBNT Kubient
$6.93 /

+0.15 (+2.21%)

Over a quarter ago
Earnings
Kubient reports Q4 EPS (28c), consensus (21c) » 16:11
03/25/21
03/25
16:11
03/25/21
16:11
KBNT

Kubient

$7.01 /

+0.23 (+3.39%)

Reports Q4 revenue $1.1M,…

Reports Q4 revenue $1.1M, consensus $500K. As of March 24, 2021, the Company had approximately $32.0 million of cash on hand. "We concluded 2020 and entered the new year with significant momentum and an underlying core theme of growth across every facet of our business," said Interim CEO Paul Roberts. "We are encouraged by the traction we've been receiving from new partners, such as Google, and The Associated Press, as we intend to develop the supply-side of the Audience Cloud with a premium base of publishers. With that said, we are continuing our sales efforts in scaling the flip side of our marketplace with brands and ad agencies to capitalize on the dollar potential and maximize ROI. *...( With KAI as a stand-alone product completed and the near consummation of our self-serve DSP, we are setting ourselves up for success. Our team has been encouraged by the expanding portfolio of products, partners, and opportunities ahead for Kubient. Going forward, as we head into our first full year as a publicly traded company, we remain optimistic about our value proposition and look forward to expanding our footprint and capitalizing on the growing tailwinds within the digital advertising ecosystem."

ShowHide Related Items >><<
KBNT Kubient
$7.01 /

+0.23 (+3.39%)

KBNT Kubient
$7.01 /

+0.23 (+3.39%)

10/27/20 Maxim
Kubient initiated with a Buy at Maxim
  • 23
    Dec
KBNT Kubient
$7.01 /

+0.23 (+3.39%)

Hot Stocks
Kubient engages Lake Street to look for mergers and acquisitions » 07:05
01/25/21
01/25
07:05
01/25/21
07:05
KBNT

Kubient

$5.59 /

+0.135 (+2.48%)

Kubient announced that it…

Kubient announced that it has engaged Lake Street Capital Markets, a research-powered investment bank focused on growth companies, to provide Merger and Acquisition services within the advertising technology ecosystem. More specifically, Lake Street will look for mergers, acquisitions, or strategic investments in complementary businesses, brands, and technologies, which will ultimately allow Kubient to provide innovative solutions for publishers and advertisers.

ShowHide Related Items >><<
KBNT Kubient
$5.59 /

+0.135 (+2.48%)

KBNT Kubient
$5.59 /

+0.135 (+2.48%)

10/27/20 Maxim
Kubient initiated with a Buy at Maxim
  • 23
    Dec
KBNT Kubient
$5.59 /

+0.135 (+2.48%)

Syndicate
Kubient 3.53M share Secondary priced at $5.10 » 21:57
12/22/20
12/22
21:57
12/22/20
21:57
KBNT

Kubient

$6.67 /

-0.34 (-4.85%)

Maxim and Joseph Gunnar…

Maxim and Joseph Gunnar acted as joint book running managers for the offering.

ShowHide Related Items >><<
KBNT Kubient
$6.67 /

-0.34 (-4.85%)

KBNT Kubient
$6.67 /

-0.34 (-4.85%)

10/27/20 Maxim
Kubient initiated with a Buy at Maxim
KBNT Kubient
$6.67 /

-0.34 (-4.85%)

Syndicate
Kubient files to sell 2.07M shares of common stock » 09:46
12/21/20
12/21
09:46
12/21/20
09:46
KBNT

Kubient

$7.54 /

+0.14 (+1.89%)

Co-book-running managers…

Co-book-running managers include Maxim Group and Joseph Gunnar & Co.

ShowHide Related Items >><<
KBNT Kubient
$7.54 /

+0.14 (+1.89%)

KBNT Kubient
$7.54 /

+0.14 (+1.89%)

10/27/20 Maxim
Kubient initiated with a Buy at Maxim
KBNT Kubient
$7.54 /

+0.14 (+1.89%)

Hot Stocks
Kubient appoints Paul Roberts as interim CEO » 16:01
11/02/20
11/02
16:01
11/02/20
16:01
KBNT

Kubient

$2.79 /

-0.1 (-3.46%)

The Board of Directors of…

The Board of Directors of Kubient, has appointed Chairman, founder and Chief Strategy Officer Paul Roberts as Interim CEO,effective October 31. Roberts succeeds Peter Bordes, who will remain at the Company in his current capacity as a director. "Following our Company's successful IPO in August, I weighed my other obligations and came to the difficult decision to step down from my day-to-day responsibilities as CEO," said Bordes. "While I plan to devote my time and energies on my family and other pursuits, I will also continue in my commitment as a director and work closely with Paul to ensure a seamless transition. Kubient has never been in a stronger position, and I look forward to supporting the leadership team from the board and as a major shareholder to realize the tremendous potential of our disruptive technology."

ShowHide Related Items >><<
KBNT Kubient
$2.79 /

-0.1 (-3.46%)

KBNT Kubient
$2.79 /

-0.1 (-3.46%)

10/27/20 Maxim
Kubient initiated with a Buy at Maxim
KBNT Kubient
$2.79 /

-0.1 (-3.46%)

Initiation
Kubient initiated with a Buy at Maxim » 08:06
10/27/20
10/27
08:06
10/27/20
08:06
KBNT

Kubient

$3.11 /

-0.28 (-8.26%)

Maxim analyst Jack Vander…

Maxim analyst Jack Vander Aarde initiated coverage of Kubient with a Buy rating and $10 price target. The analyst cites the company's efforts to "disrupt" the $325B digital advertising industry, noting that it is positioned for a "solid growth inflection year" with expected net income margin expansion of over 20%. Vander Aarde further cites Kubient's "solid" balance sheet and attractive valuation of 0.9-times enterprise value to his expected 2022 revenue vs. the peers' multiple of 5.6-times.

ShowHide Related Items >><<
KBNT Kubient
$3.11 /

-0.28 (-8.26%)

KBNT Kubient
$3.11 /

-0.28 (-8.26%)

On The Fly
Fly Insider: Element Solutions, Sunrun among week's notable insider trades » 14:18
10/12/20
10/12
14:18
10/12/20
14:18
ARQT

Arcutis Biotherapeutics

$24.25 /

+0.11 (+0.46%)

, MCHX

Marchex

$2.12 /

-0.04 (-1.85%)

, ESI

Element Solutions

$12.27 /

+0.045 (+0.37%)

, SELB

Selecta Biosciences

$2.03 /

+0.005 (+0.25%)

, KBNT

Kubient

$2.75 /

+0.03 (+1.10%)

, RUN

Sunrun

$65.45 /

-5.94 (-8.32%)

, MIK

Michaels

$9.88 /

-0.16 (-1.59%)

, BE

Bloom Energy

$22.46 /

-0.45 (-1.96%)

, NOVA

Sunnova Energy

$28.60 /

-0.695 (-2.37%)

, CRSR

Corsair Gaming

$18.55 /

+0.55 (+3.06%)

Welcome to "Fly Insider,"…

ShowHide Related Items >><<
SELB Selecta Biosciences
$2.03 /

+0.005 (+0.25%)

RUN Sunrun
$65.45 /

-5.94 (-8.32%)

NOVA Sunnova Energy
$28.60 /

-0.695 (-2.37%)

MIK Michaels
$9.88 /

-0.16 (-1.59%)

MCHX Marchex
$2.12 /

-0.04 (-1.85%)

KBNT Kubient
$2.75 /

+0.03 (+1.10%)

ESI Element Solutions
$12.27 /

+0.045 (+0.37%)

BE Bloom Energy
$22.46 /

-0.45 (-1.96%)

ARQT Arcutis Biotherapeutics
$24.25 /

+0.11 (+0.46%)

ARQT Arcutis Biotherapeutics
$24.25 /

+0.11 (+0.46%)

10/08/20 Truist
Arcutis Biotherapeutics initiated with a Buy at Truist
10/08/20 Truist
Arcutis Biotherapeutics initiated with a Buy at Truist
03/20/20 Cantor Fitzgerald
Arcutis dermatology potential remains underappreciated, says Cantor Fitzgerald
02/25/20 Guggenheim
Guggenheim starts Arcutis Biotherapeutics with Buy, $36 price target
MCHX Marchex
$2.12 /

-0.04 (-1.85%)

ESI Element Solutions
$12.27 /

+0.045 (+0.37%)

04/20/20 Truist
Element Solutions upgraded to Buy from Hold at SunTrust
11/18/19 Goldman Sachs
Element Solutions upgraded to Buy from Neutral at Goldman Sachs
SELB Selecta Biosciences
$2.03 /

+0.005 (+0.25%)

10/05/20 H.C. Wainwright
Selecta Biosciences price target lowered to $6 from $10 at H.C. Wainwright
10/01/20
Fly Intel: Top five analyst downgrades
10/01/20 Stifel
Stifel halves Selecta Biosciences target to $2, sees 'no reason to buy here'
10/01/20 Mizuho
Selecta downgraded to Neutral with $2.50 target at Mizuho
KBNT Kubient
$2.75 /

+0.03 (+1.10%)

RUN Sunrun
$65.45 /

-5.94 (-8.32%)

10/07/20 Piper Sandler
Sunrun initiated with a Neutral at Piper Sandler
10/06/20 GLJ Research
SunPower upgraded to Buy from Sell at GLJ Research
09/30/20
Fly Intel: Top five analyst downgrades
09/30/20 JPMorgan
Sunrun price target raised to $79 from $61 at JPMorgan
MIK Michaels
$9.88 /

-0.16 (-1.59%)

09/25/20 Loop Capital
Michaels price target raised to $25 from $20 at Loop Capital
09/25/20 Morgan Stanley
Morgan Stanley ups Michaels price target to $7, questions ability to meet goals
09/04/20
Fly Intel: Top five analyst upgrades
09/04/20 JPMorgan
JPMorgan boosts Michaels target to $16, calls selloff 'highly irrational'
BE Bloom Energy
$22.46 /

-0.45 (-1.96%)

07/29/20 Credit Suisse
Weakness in Bloom Energy shares 'well overdone,' says Credit Suisse
07/16/20 Morgan Stanley
Bloom Energy adds upside potential with hydrogen entry, says Morgan Stanley
05/28/20 JPMorgan
Bloom Energy price target raised to $17 from $14 at JPMorgan
05/12/20 Morgan Stanley
Bloom Energy's underlying demand still appears strong, says Morgan Stanley
NOVA Sunnova Energy
$28.60 /

-0.695 (-2.37%)

10/07/20 Piper Sandler
Sunnova Energy initiated with an Overweight at Piper Sandler
09/30/20 JPMorgan
Sunnova Energy assumed with an Overweight at JPMorgan
09/30/20 Roth Capital
Short report on Sunnova Energy 'misses the mark,' says Roth Capital
09/23/20 B. Riley
Sunnova Energy initiated with a Buy at B. Riley FBR
CRSR Corsair Gaming
$18.55 /

+0.55 (+3.06%)

SELB Selecta Biosciences
$2.03 /

+0.005 (+0.25%)

RUN Sunrun
$65.45 /

-5.94 (-8.32%)

NOVA Sunnova Energy
$28.60 /

-0.695 (-2.37%)

MIK Michaels
$9.88 /

-0.16 (-1.59%)

MCHX Marchex
$2.12 /

-0.04 (-1.85%)

BE Bloom Energy
$22.46 /

-0.45 (-1.96%)

ARQT Arcutis Biotherapeutics
$24.25 /

+0.11 (+0.46%)

  • 02
    Oct
  • 02
    Oct
  • 23
    Sep
  • 14
    Aug
  • 01
    Jul
  • 31
    Jan
MIK Michaels
$9.88 /

-0.16 (-1.59%)

BE Bloom Energy
$22.46 /

-0.45 (-1.96%)

SELB Selecta Biosciences
$2.03 /

+0.005 (+0.25%)

RUN Sunrun
$65.45 /

-5.94 (-8.32%)

MIK Michaels
$9.88 /

-0.16 (-1.59%)

CRSR Corsair Gaming
$18.55 /

+0.55 (+3.06%)

BE Bloom Energy
$22.46 /

-0.45 (-1.96%)

ARQT Arcutis Biotherapeutics
$24.25 /

+0.11 (+0.46%)

RUN Sunrun
$65.45 /

-5.94 (-8.32%)

NOVA Sunnova Energy
$28.60 /

-0.695 (-2.37%)

MIK Michaels
$9.88 /

-0.16 (-1.59%)

MCHX Marchex
$2.12 /

-0.04 (-1.85%)

ESI Element Solutions
$12.27 /

+0.045 (+0.37%)

BE Bloom Energy
$22.46 /

-0.45 (-1.96%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.